(Reuters) - Rogers Communications said on Wednesday Deputy Chair Melinda Rogers-Hixon and Martha Rogers have decided to retire from the Canadian telecom giant's board as part of a private settlement between the members of the founding family. The wireless carrier…
(Reuters) -Citigroup pushed forward its forecast of the U.S. Federal Reserve's 25 basis-point interest rate cut to June from July, citing the central bank's dovish stance, falling inflation, and rising pressures from geopolitical risks. The brokerage said on Wednesday it…
By Hannah Lang, Suzanne McGee and Manya Saini (Reuters) - U.S.-listed bitcoin exchange-traded funds (ETFs) saw $4.6 billion worth of shares trade hands as of Thursday afternoon, according to LSEG data, as investors jumped into the landmark products approved by…
By Chuck Mikolajczak NEW YORK (Reuters) -U.S. stocks closed higher on Wednesday as megacaps rallied, but gains were limited ahead of inflation reports and major bank earnings later in the week. Microsoft, Meta Platforms and Nvidia were the biggest boosts…
(Reuters) -More than 20 million Americans have so far signed up for health insurance through the Affordable Care Act's (ACA) marketplace for this year, the highest since the inception of the law, according to data released on Wednesday. Over 3.7…
(Reuters) -Hewlett Packard Enterprise will buy networking gear maker Juniper Networks for $14 billion in an all-cash deal, in an attempt to spruce up the company's artificial intelligence (AI) offerings. HPE offered $40 per share to Juniper shareholders, the companies…
By Will Dunham (Reuters) - DNA obtained from the bones and teeth of ancient Europeans who lived up to 34,000 years ago is providing insight into the origin of the often-disabling neurological disease multiple sclerosis, finding that genetic variants that…
(Reuters) -Apple continued its struggle in the new year on Thursday, plumbing an eight-week low after Piper Sandler handed the tech giant its second downgrade this week on worries about iPhone demand. The rating action knocked Apple shares down 1.4%…
By Manas Mishra and Pratik Jain (Reuters) - The U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an improvement analysts and investors said could…
By Caroline Valetkevitch NEW YORK (Reuters) - U.S. corporate earnings should improve at a stronger clip in 2024 as inflation and interest rates come down, analysts predict, but worries about slowing economic growth hang over the outlook. S&P 500 earnings…